Bypassing the restriction barrier to improve transformation in S. epidermidis
Bypassing the restriction barrier to improve transformation in S. epidermidis
批准号:
9386188
负责人:
Ambrose Lin Yau Cheung
金额:
$20.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-06-27 至 2019-05-31
关键词:
AdenineAntibiotic ResistanceBacteremiaBacteriaBlood CirculationBlood VesselsBypassCathetersClinicalCloningCommunitiesComplexCytosineDNADNA Restriction EnzymesDNA Restriction-Modification EnzymesDevicesEscherichia coliEscherichia coli K12ExcisionGenesGeneticGenomeGenomicsGenus staphylococcusGoalsHip ProsthesisHospitalsHumanIn VitroIndividualIndolentInfectionKnowledgeLaboratoriesLibrariesMediatingMedical DeviceMethylationMethyltransferaseMicrobial BiofilmsMindModificationMorbidity - disease rateMucous MembraneNosocomial InfectionsOrganismPacemakersPathogenesisPathogenicityPhasePhysiologyPilot ProjectsPlasmidsPositioning AttributeProcessProkaryotic CellsProsthesisPublishingReportingResearchResearch PersonnelSeriesSiteSkinSpecific qualifier valueSpecificityStaphylococcus aureusStaphylococcus epidermidisSurfaceSymbiosisSystemTimeUniversity HospitalsVirulentWorkantimicrobialbasedesignimprovedin vivomethylation patternnovel strategiespathogenplasmid DNApreventsingle moleculesuccessuptakevirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Staphylococcus epidermidis (SE) ranks as one of the most common causes of nosocomial infections in US
hospitals. Intravascular devices and prostheses are the usual sites of infection followed by seeding of the
bloodstream. Although more indolent than S. aureus, SE infections are difficult to treat due to its persistence
as biofilm on abiotic surfaces as well as its penchant for antibiotic resistance. There are two major issues in
advancing our understanding of SE pathogenesis: 1) prior work has focused on two laboratory isolates, SE
1457 and RP62A while our knowledge on clinical isolates are virtually non-existent; 2) SE clinical isolates are
extremely difficult to transform due to its formidable restriction barrier. As a consequence, we lack the ability to
manipulate clinical isolates genetically to dissect the relevant pathogenic steps leading to colonization, biofilm
formation, persistence and dissemination. With the advance of genomics and SMRT sequencing, we are in a
unique position to analyze the methylation pattern of the restriction modification (RM) system based on the
specificity unit (HsdS) and methylase (HsdM). There are four RM systems in SE (types I-IV). Type 1 and type
IV are the major restriction barriers that prevent uptake of foreign DNA due to restriction by HsdR. We will
exploit the RM system by methylating adenine in plasmid DNA with type I cognate HsdMS complex(es) in E.
coli DC10B which is defective in cytosine methylation and can bypass the type IV RM system. While type IV
RM system is conserved among S. aureus and SE, the type I RM system is more variable and entails at least
7 distinct groups, each with its unique target recognition motif (TRM) mediated by HsdS. These discrepancies
help explain the differences in restriction among SE isolates. We hypothesize that type 1 RM system in a
particular SE isolate can be completely bypassed to yield efficient transformation by cloning shuttle plasmids in
DC10B that express the cognate hsdMS genes. With this goal is mind, we propose the following two specific
aims: I) determine the different groups in type I RM system by performing Pacbio single molecule real time
sequencing (SMRT) to detect methylated-adenine residues and the target recognition motif of the HsdMS
complex in the SE genomes; II) Construction of DC10B-derived E. coli strains to enable efficient
transformation into diverse SE strains. As a utility from this system, we will construct two relevant mariner
transposon libraries to be available to the research community.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Membrane-active quinoline and quinazoline antibacterials that target Gram positive pathogens
-
批准号:9973439
-
项目类别:
-
资助金额:$78.29万
-
财政年份:2020
-
负责人:Ambrose Lin Yau Cheung
-
依托单位:
Membrane-active quinoline and quinazoline antibacterials that target Gram positive pathogens
-
批准号:10563142
-
项目类别:
-
资助金额:$79.94万
-
财政年份:2020
-
负责人:Ambrose Lin Yau Cheung
-
依托单位:
Membrane-active quinoline and quinazoline antibacterials that target Gram positive pathogens
-
批准号:10331864
-
项目类别:
-
资助金额:$76.52万
-
财政年份:2020
-
负责人:Ambrose Lin Yau Cheung
-
依托单位:
Membrane-active quinoline and quinazoline antibacterials that target Gram positive pathogens
-
批准号:10117071
-
项目类别:
-
资助金额:$76.46万
-
财政年份:2020
-
负责人:Ambrose Lin Yau Cheung
-
依托单位:
Optimization of a novel compound that enhances the activity of beta-lactams against Gram+ bacteria
-
批准号:9296686
-
项目类别:
-
资助金额:$21.24万
-
财政年份:2017
-
负责人:Ambrose Lin Yau Cheung
-
依托单位:
Regulation of SsrA-mediated proteolysis of S. aureus
-
批准号:8951755
-
项目类别:
-
资助金额:$20.25万
-
财政年份:2015
-
负责人:Ambrose Lin Yau Cheung
-
依托单位:
Regulation of SsrA-mediated proteolysis of S. aureus
-
批准号:9089861
-
项目类别:
-
资助金额:$24.3万
-
财政年份:2015
-
负责人:Ambrose Lin Yau Cheung
-
依托单位:
The role of CshA and CshB in selective mRNA protection in S. aureus
-
批准号:8665389
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2013
-
负责人:Ambrose Lin Yau Cheung
-
依托单位:
The role of CshA and CshB in selective mRNA protection in S. aureus
-
批准号:8830428
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2013
-
负责人:Ambrose Lin Yau Cheung
-
依托单位:
The role of CshA and CshB in selective mRNA protection in S. aureus
-
批准号:8557227
-
项目类别:
-
资助金额:$38.05万
-
财政年份:2013
-
负责人:Ambrose Lin Yau Cheung
-
依托单位:
The role of GraRS in resistance to cationic antimicrobial peptides in S. aureus
-
批准号:8023804
-
项目类别:
-
资助金额:$49.95万
-
财政年份:2010
-
负责人:Ambrose Lin Yau Cheung
-
依托单位:
The role of GraRS in resistance to cationic antimicrobial peptides in S. aureus
-
批准号:8390496
-
项目类别:
-
资助金额:$45.78万
-
财政年份:2010
-
负责人:Ambrose Lin Yau Cheung
-
依托单位:
The role of GraRS in resistance to cationic antimicrobial peptides in S. aureus
-
批准号:8582532
-
项目类别:
-
资助金额:$48.7万
-
财政年份:2010
-
负责人:Ambrose Lin Yau Cheung
-
依托单位:
The role of GraRS in resistance to cationic antimicrobial peptides in S. aureus
-
批准号:8770008
-
项目类别:
-
资助金额:$48.7万
-
财政年份:2010
-
负责人:Ambrose Lin Yau Cheung
-
依托单位:
The role of GraRS in resistance to cationic antimicrobial peptides in S. aureus
-
批准号:8197469
-
项目类别:
-
资助金额:$49.21万
-
财政年份:2010
-
负责人:Ambrose Lin Yau Cheung
-
依托单位:
Defining the bacterial factors that modulate sensitivity to B-lactam in CA-MRSA
-
批准号:7580177
-
项目类别:
-
资助金额:$19.99万
-
财政年份:2009
-
负责人:Ambrose Lin Yau Cheung
-
依托单位:
Defining the bacterial factors that modulate sensitivity to B-lactam in CA-MRSA
-
批准号:7754871
-
项目类别:
-
资助金额:$23.75万
-
财政年份:2009
-
负责人:Ambrose Lin Yau Cheung
-
依托单位:
The toxin-antitoxin system of Staphylococcus aureus.
-
批准号:7590118
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2009
-
负责人:Ambrose Lin Yau Cheung
-
依托单位:
Defining the bacterial factors that modulate sensitivity to B-lactam in CA-MRSA
-
批准号:7846515
-
项目类别:
-
资助金额:$3.95万
-
财政年份:2009
-
负责人:Ambrose Lin Yau Cheung
-
依托单位:
The toxin-antitoxin system of Staphylococcus aureus.
-
批准号:7897800
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2009
-
负责人:Ambrose Lin Yau Cheung
-
依托单位:
海外基金